Sanofi raises guidance as new CEO looks to revamp drug pipeline

MSN

Jul 30, 2026 at 01:04 AM

The company now expects 2026 sales to grow by around 10% excluding currency changes, with business earnings per share rising slightly faster than sales.

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.